Stroke Recurrence in First-Ever Symptomatic Carotid Web: A Cohort Study
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Carotid web (CaW) is an intimal variant of fibromuscular dysplasia responsible for ipsilateral cerebral ischemic events (CIE). Symptomatic CaW likely has a high risk of recurrent CIE, but no salient prospective data are available. We aimed to assess recurrence rate and its predictors after a first-ever CIE. Methods Consecutive Afro-Caribbean patients who had cryptogenic first-ever CIEs (ischemic stroke [IS] or transient ischemic attack [TIA]) associated with ipsilateral CaW were included in this multicenter observational cohort study. The follow-up (January 2008 to March 2019) focused on CIE recurrences. Kaplan-Meier method assessed rates of recurrences and Cox proportional hazards regression analyzed risk factors. Results Ninety-two patients (79 first-ever ISs and 13 TIAs; mean age±standard deviation, 49.8±9.9 years; 52 [56.5%] women) were included. During a mean follow-up of 50.5±29.6 months, 19 (20.7%) patients experienced recurrent ipsilateral CIEs (16 ISs and three TIAs). Of 23 patients receiving surgery/stenting treatment, no recurrence occurred after the intervention (median follow-up, 39.8 months [interquartile range, 27.6 to 72.4]). Under medical treatment alone, the annual recurrent CIE rate was 6.9%, and the cumulative rate was 4.4% at 30-day, 10.8% at 1-year, 19.8% at 2-year, 23.2% at 3-year, and 27.3% at 5-year. Presence of silent cerebral infarctions was the only independent risk factor of CIE recurrences (hazard ratio, 6.99; 95% confidence interval, 2.4 to 20.4; P=0.004). Conclusions Under medical treatment alone, symptomatic CaW was associated with a high rate of recurrence that reached 27.3% at 5-year. Surgery/stenting seems to be efficient, and randomized control trials are required to confirm the benefit of these interventions.
Abstract
Background and Purpose Carotid web (CaW) is an intimal variant of fibromuscular dysplasia responsible for ipsilateral cerebral ischemic events (CIE). Symptomatic CaW likely has a high risk of recurrent CIE, but no salient prospective data are available. We aimed to assess recurrence rate and its predictors after a first-ever CIE. Methods Consecutive Afro-Caribbean patients who had cryptogenic first-ever CIEs (ischemic stroke [IS] or transient ischemic attack [TIA]) associated with ipsilateral CaW were included in this multicenter observational cohort study. The follow-up (January 2008 to March 2019) focused on CIE recurrences. Kaplan-Meier method assessed rates of recurrences and Cox proportional hazards regression analyzed risk factors. Results Ninety-two patients (79 first-ever ISs and 13 TIAs; mean age±standard deviation, 49.8±9.9 years; 52 [56.5%] women) were included. During a mean follow-up of 50.5±29.6 months, 19 (20.7%) patients experienced recurrent ipsilateral CIEs (16 ISs and three TIAs). Of 23 patients receiving surgery/stenting treatment, no recurrence occurred after the intervention (median follow-up, 39.8 months [interquartile range, 27.6 to 72.4]). Under medical treatment alone, the annual recurrent CIE rate was 6.9%, and the cumulative rate was 4.4% at 30-day, 10.8% at 1-year, 19.8% at 2-year, 23.2% at 3-year, and 27.3% at 5-year. Presence of silent cerebral infarctions was the only independent risk factor of CIE recurrences (hazard ratio, 6.99; 95% confidence interval, 2.4 to 20.4; P=0.004). Conclusions Under medical treatment alone, symptomatic CaW was associated with a high rate of recurrence that reached 27.3% at 5-year. Surgery/stenting seems to be efficient, and randomized control trials are required to confirm the benefit of these interventions.
참고문헌 (31)
- Wirth FP, "Atypical fibromuscular hyperplasia. Report of two cases", J Neurosurg, 54, pp.685~689 (1981)
- Morgenlander JC, "Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web", Stroke, 22, pp.94~98 (1991)
- Joux J, "Carotid-bulb atypical fibromuscular dysplasia in young Afro-Caribbean patients with stroke", Stroke, 45, pp.3711~3713 (2014)
- Joux J, "Association between carotid bulb diaphragm and ischemic stroke in young Afro-Caribbean patients : a population-based case-control study", Stroke, 47, pp.2641~2644 (2016)
- Coutinho JM, "Carotid artery web and ischemic stroke : a case-control study", Neurology, 88, pp.65~69 (2017)
- Sajedi PI, "Carotid bulb webs as a cause of"cryptogenic"ischemic stroke", AJNR Am J Neuroradiol, 38, pp.1399~1404 (2017)
- Kim SJ, "Carotid webs in cryptogenic ischemic strokes : a matched case-control study", J Stroke Cerebrovasc Dis, 28, pp.104402~ (2019)
- Kubis N, "Thrombotic carotid megabulb: fibromuscular dysplasia, septae, and ischemic stroke", Neurology, 52, pp.883~886 (1999)
- S. Olindo, "Carotid webs associated with ischemic stroke. Updated general review and research directions", Revue Neurologique, 177(6), pp.627~638 (2021), Elsevier BV[DOI]
- Compagne KCJ, "Flow patterns in carotid webs : a patient-based computational fluid dynamics study", AJNR Am J Neuroradiol, 40, pp.703~708 (2019)
- Haussen DC, "Carotid web(intimal fibromuscular dysplasia)has high stroke recurrence risk and is amenable to stenting", Stroke, 48, pp.3134~3137 (2017)
- Compagne KCJ, "Prevalence of carotid web in patients with acute intracranial stroke due to intracranial large vessel occlusion", Radiology, 286, pp.1000~1007 (2018)
- Choi PM, "Carotid webs and recurrent ischemic strokes in the era of CT angiography", AJNR Am J Neuroradiol, 36, pp.2134~2139 (2015)
- Barber PA, "Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score", Lancet, 355, pp.1670~1674 (2000)
- Sacco RL, "An updated definition of stroke for the 21st century : a statement for healthcare professionals from the American Heart Association", American Stroke Association, 2013, pp.44, 2064~2089
- Madaelil TP, "Multimodality imaging in carotid web", Front Neurol, 10, pp.220~ (2019)
- European Carotid Surgery Trialists’ Collaborative Group, "MRC European Carotid Surgery Trial : interim results for symptomatic patients with severe(70-99%)or with mild(0-29%)carotid stenosis", Lancet, 337, pp.1235~1243 (1991)
- So EL, "Cerebral embolism from septal fibromuscular dysplasia of the common carotid artery", Ann Neurol, 6, pp.75~78 (1979)
- Zhang AJ, "A systematic literature review of patients with carotid web and acute ischemic stroke", Stroke, 49, pp.2872~2876 (2018)
- Mac Grory B, "Cryptogenic stroke : diagnostic workup and management", Curr Treat Options Cardiovasc Med, 21, pp.77~ (2019)
- Putaala J, "Recurrent ischemic events in young adults after first-ever ischemic stroke", Ann Neurol, 68, pp.661~671 (2010)
- Diener HC, "Dabigatran for prevention of stroke after embolic stroke of undetermined source", N Engl J Med, 380, pp.1906~1917 (2019)
- Ahmad Y, "Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials", Eur Heart J, 39, pp.1638~1649 (2018)
- Verscheure D, "Symptomatic carotid-bulb atypical fibromuscular dysplasia", Ann Vasc Surg, 43, pp.310~ (2017)
- Pereira BJA, "Web vessels : literature review and neurointerventional management", World Neurosurg, 110, pp.e907~e916 (2018)
- Multon S, "Carotid webs management in symptomatic patients", J Vasc Surg, 73, pp.1290~1297 (2021)
- Brinjikji W, "Carotid stenting for treatment of symptomatic carotid webs : a single-center case series", Interv Neurol, 7, pp.233~240 (2018)
- Haussen DC, "Multicenter experience with stenting for symptomatic carotid web", Interv Neurol, 7, pp.413~418 (2018)
- Wojcik K, "Survey of current management practices for carotid webs", Ochsner J, 19, pp.296~302 (2019)
- Renoux C, "Confounding by pre-morbid functional status in studies of apparent sex differences in severity and outcome of stroke", Stroke, 48, pp.2731~2738 (2017)
- Olindo S, "One-year disability, death and recurrence after first-ever stroke in a Black Afro-Caribbean population", Int J Stroke, 12, pp.844~850 (2017)